Latest Publication: Pilot Study Results in Kidney International Reports→
Veripath

AI-Powered Tissue Assessment Platform

Deliver real-time adequacy insights from any biopsy sample—starting with kidney

How It Works

Capture
Take a high-resolution photo of the kidney biopsy sample using your smartphone.
Upload
Our application will securely upload the image to our web-based platform.
Analyze
Our AI model instantly processes the image, providing real-time adequacy assessment.

Use Case: Kidney Biopsy

Cortex Identification
Automatically highlights cortex regions with >95% detection accuracy.
Quantitative Assessment
Calculates cortex percentage to 0.1% precision.
Validated in Pilot Study
Dice Similarity Coefficient: 0.73 ± 0.27 (n = 200)

Platform Capabilities

Multi-Tissue Support
Adaptable to kidney, liver, lung, and more
Clinician-Centric Deployment
Intuitive, no-code setup lets labs start using within minutes with virtually no IT support required.
Scalable Cloud
Handles thousands of slides daily with end-to-end encryption

Benefits

Clinician Benefits

  • Immediate Results

    Obtain real-time adequacy assessments, reducing procedure time and patient discomfort.

  • Reduced Repeat Biopsies

    Minimize the need for repeat procedures, lowering patient risk and healthcare costs.

  • Enhanced Confidence

    Gain greater assurance in biopsy adequacy, leading to more accurate diagnoses.

Operational Benefits

  • Lower Per-Case Costs

    Reduce operational expenses through improved procedure efficiency and fewer repeats.

  • Faster Turnaround

    Accelerate diagnosis workflow with immediate adequacy feedback.

  • Supports Clinical Trials

    AI-driven on-site triage raises sample adequacy from ~50% to over 90%, cutting repeat biopsies, protocol deviations, and trial delays

Clinical Studies Support

Enhanced Sample Adequacy

Raises sample adequacy from ~50% to over 90% with AI-driven assessment

Reduced Protocol Deviations

Minimize trial protocol deviations through real-time adequacy validation

Accelerated Study Timelines

Cut trial delays by reducing repeat biopsies and improving data quality

Ready to Transform Your Biopsy Procedures?

Experience the future of tissue assessment with our AI-powered solution.

Contact Sales